Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-04-05 Purchase |
2022-04-07 6:26 pm |
MoonLake Immunotherapeutics | MLTX | Chen Bihua 10% Owner |
2,850,000 | $10 | $28,500,000 | 2,850,000 (Indirect) |
View |
2020-10-22 Purchase |
2020-10-22 5:10 pm |
Helix Acquisition Corp | HLXA | Chen Bihua CEO and Chairman 10% Owner |
430,000 | $10 | $4,300,000 | 430,000 (Indirect) |
View |
2020-10-22 Purchase |
2020-10-22 5:08 pm |
Helix Acquisition Corp | HLXA | Helix Holdings LLC Director 10% Owner |
430,000 | $10 | $4,300,000 | 430,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2022-04-15 5:26 pm |
N/A N/A |
MoonLake Immunotherapeutics | MLTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner |
0 | $0 | 21,691,694 (Direct) |
View |
Ownership |
2022-04-15 4:07 pm |
N/A N/A |
MoonLake Immunotherapeutics | MLTX | Reich Kristian Chief Scientific Officer |
0 | $0 | 3,463,870 (Indirect) |
View |
Ownership |
2022-04-15 4:07 pm |
N/A N/A |
MoonLake Immunotherapeutics | MLTX | Santos da Silva Jorge Chief Executive Officer |
0 | $0 | 3,463,870 (Direct) |
View |
Ownership |
2022-04-15 4:06 pm |
N/A N/A |
MoonLake Immunotherapeutics | MLTX | Sturge Simon Director |
0 | $0 | 353,176 (Direct) |
View |
Ownership |
2022-04-15 4:06 pm |
N/A N/A |
MoonLake Immunotherapeutics | MLTX | Bodenstedt Matthias Chief Financial Officer |
0 | $0 | 942,588 (Direct) |
View |
2022-04-05 Conversion |
2022-04-07 6:28 pm |
N/A N/A |
MoonLake Immunotherapeutics | MLTX | Helix Holdings LLC Former 10% Holder |
2,785,000 | $0 | 3,215,000 (Direct) |
View |
2022-04-05 Conversion |
2022-04-07 6:26 pm |
N/A N/A |
MoonLake Immunotherapeutics | MLTX | Chen Bihua 10% Owner |
2,785,000 | $0 | 2,850,000 (Indirect) |
View |
Ownership |
2020-10-19 9:15 pm |
N/A N/A |
Helix Acquisition Corp | HLXA | Chen Bihua CEO and Chairman 10% Owner |
0 | $0 | 2,785,000 (Indirect) |
View |
Ownership |
2020-10-19 9:13 pm |
N/A N/A |
Helix Acquisition Corp | HLXA | Lewis Will Director |
0 | $0 | 30,000 (Direct) |
View |
Ownership |
2020-10-19 9:12 pm |
N/A N/A |
Helix Acquisition Corp | HLXA | Helix Holdings LLC Director 10% Owner |
0 | $0 | 2,785,000 (Direct) |
View |
Ownership |
2020-10-19 9:11 pm |
N/A N/A |
Helix Acquisition Corp | HLXA | CHANG NANCY T Director |
0 | $0 | 30,000 (Direct) |
View |
Ownership |
2020-10-19 9:08 pm |
N/A N/A |
Helix Acquisition Corp | HLXA | Schmid John P. Director |
0 | $0 | 30,000 (Direct) |
View |